Senator Norm Coleman

After dedicating more than three decades to public service, Senator Coleman is presently Of Counsel with Hogan Lovells US LLP. He was a student activist in the 1960s, Minnesota’s chief prosecutor and Solicitor General in the 1970s and 1980s, and mayor of St. Paul in the 1990s. He represented Minnesota in the U.S. Senate from 2003 to 2009. During his six years in the U.S. Senate, Senator Coleman served on the prestigious Foreign Relations Committee. Committed to furthering innovation in medical technology, Senator Coleman co-chaired the Senate Medical Technology Caucus. He worked closely with companies to help bring novel life-saving technologies to the public. In 2007, he introduced the Hope Offered through Principled and Ethical Stem Cell Research Act (HOPE). The bill would have provided $5 billion for research to derive pluripotent stem cells using techniques that did not involve the destruction of a human embryo. The bill passed the Senate by a 70-28 margin. The House of Representatives, under the leadership of Speaker Nancy Pelosi, refused to take up the bill.

Senator Coleman served on the Homeland Security Committee and chaired the Permanent Subcommittee on Investigations. Under his leadership, the Subcommittee identified more than $80 billion in waste, fraud, abuse, and potential taxpayer savings.

Senator Coleman serves as chairman of the board of the American Action Network, a center-right “action tank” located in Washington, D.C. He also sits on the board of the Network’s sister organization, the American Action Forum, a forward-looking policy institute dedicated to keeping America strong, free, and prosperous. He is chairman of the Congressional Leadership Fund, an independent expenditure “super PAC” whose mission is to retain and expand the House Republican majority.

He serves on the Board of the National Endowment for Democracy and is a member of the Advisory Council of the US Global Leadership Coalition.

Leave a Reply

Your email address will not be published. Required fields are marked *